Close Menu
Home › Andrea Anderson

Andrea Anderson

Contributor
Phone Number
+1-780-990-0086
Email
anderson@genomeweb.com
Andrea Anderson Andrea Anderson

Andrea Anderson covers genomics research studies and translational research for GenomeWeb. Find her on Twitter at @andyandy_tk.

Articles Authored by Andrea Anderson

Jul 09, 2019

BEACON Trial Reports Survival Benefit for Triple Targeted Treatment in BRAF-Mutated Metastatic CRC

An international team saw an overall survival benefit when using BRAF, MEK, and EGFR inhibitors together in previously treated, BRAF-mutated metastatic colorectal cancer patients.

Jul 08, 2019

Clinical Trials Use PET Tracer to Track PARP-1 Levels in Relation to Patient Outcomes

Premium

A modified analogue of rucaparib is being used to track PARP-1 expression in PARP inhibitor-treated patients with pancreatic, breast, prostate, and other cancer types.

Jun 25, 2019

Consortium Sets Out to Bring Precision Medicine Approaches to Very Rare Cancers in NY

Premium

A New York Genome Consortium-led team plans retrospective and prospective analyses on very rare cancers in the hopes of improving treatment options available for patients.

Jun 05, 2019

Pilot Projects to Assess Newly Released mCODE Proposals for Cancer-Related EHR Standardization

The mCODE team recently released standards for inputting genomic and other data into patient records to boost patient record transferability and trial participation.

Jun 04, 2019

Color Panel Reveals Hereditary Cancer Risk in Trinidad and Tobago Breast Cancer Patients

Premium

By profiling hereditary risk variants in women with breast cancer, researchers hope to lay the foundation for future genetic testing programs in the Caribbean country.

Jun 03, 2019

Lynparza Delays Progression in Metastatic Pancreatic Cancer Patients With Germline BRCA Mutations

Premium

Olaparib maintenance therapy stretched out progression-free survival, suggesting a need for germline BRCA1/2 mutation testing in pancreatic cancer patients.

Jun 02, 2019

CDK4/6 Inhibitor Boosts Overall Survival in Advanced, Premenopausal Breast Cancer Subgroup

Premium

Results from a Phase III trial presented at ASCO suggest a significant overall survival increase by adding ribociclib to endocrine therapy in HR-positive, HER2-negative breast cancer.

May 30, 2019

PreCancer Atlas Attempts to Push Precision Medicine to Early-Stage Disease

Premium

Cancer Moonshot-funded teams are profiling pre-cancers in an effort to establish targeted treatment, detection, and prevention methods that can be applied before cancers form.

Apr 08, 2019

Cancer Sequencing Finds Germline Risk Variants in Many CHOP Pediatric Cancer Cases

At the ACMG meeting, a Children's Hospital of Philadelphia researcher described finding relatively high rates of hereditary cancer variants in tumor sequence data.

Apr 08, 2019

Expanded Germline Panel Testing in Cancer Patients Catches Risk Variants Missed by Focused Tests

Research presented at ACMG by Invitae suggests that clinically actionable variants in cancer patients are missed by germline testing that is not done with expanded panels.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.